Revascularization in a Septic or Potentially Septic Environment
Conditions
Brief summary
This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8°C as part of an arterial revascularization in a septic environment in either of the two centers between January 2024 and January 2025 will be included. Imaging exams and clinical follow-up data will be analyzed. Reinterventions and causes of death will be recorded. All imaging required for the 6-month follow-up is routinely performed as part of standard care. No modification of patient management is planned.
Interventions
PROCEDUREarterial revascularization
arterial revascularization
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Adult patient * Requiring revascularization in a septic or high-risk septic environment * With an estimated life expectancy of 12 months or more based on medical and surgical assessment * Informed about the study
Exclusion criteria
* Pregnant women * Individuals for whom regular medical follow-up cannot be ensured
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To evaluate the 6-month primary patency of revascularizations using arterial allografts preserved at +2 to +8°C | 6 month | Evaluation of the 6-month primary patency of the revascularization, defined as the percentage of patients with a patent bypass without reintervention or \>50% stenosis, confirmed by a morphological imaging exam (Doppler ultrasound or CT angiography) performed at 6 months |
Countries
France
Outcome results
None listed